Prof. Richard Gilbert
Honorary
Medicine - St Vincent's Hospital
123 Scholarly works
16 Projects
HIGHLIGHTS
2020
Journal article
Renal microvascular oxygen tension during hyperoxia and acute hemodilution assessed by phosphorescence quenching and excitation with blue and red light
DOI: 10.1007/s12630-020-01848-52020
Conference Proceedings
Dapagliflozin induces kidney augmentation: potentialmechanism for SGLT2 inhibitor induced nephroprotection
2020
Journal article
Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline
DOI: 10.1186/s12882-020-01943-12020
Journal article
The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial
DOI: 10.1093/ndt/gfz2942020
Journal article
Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children
DOI: 10.1016/j.cjca.2020.02.0862020
Journal article
Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical Trial
DOI: 10.1016/j.echo.2020.02.0052020
Journal article
Renal tissue PO2 sensing during acute hemodilution is dependent on the diluent
DOI: 10.1152/ajpregu.00323.2019
RECENT SCHOLARLY WORKS
2020
Journal article
Effect of Empagliflozin on Erythropoietin Levels, Iron Stores, and Red Blood Cell Morphology in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
DOI: 10.1161/CIRCULATIONAHA.119.0442352019
Journal article
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease The EMPA-HEART CardioLink-6 Randomized Clinical Trial
DOI: 10.1161/CIRCULATIONAHA.119.0423752019
Journal article
Diabetic kidney disease 2.0: the treatment paradigm shifts
DOI: 10.1016/S2213-8587(19)30253-02019
Conference Proceedings
Tubular protection with empagliflozin treatment in subjects with type 2 diabetes and cardiovascular disease: a sub-analysis of the EMPA-HEART CardioLink-6 trial
2019
Journal article
Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: A meta-analysis of cardiovascular outcome trials
DOI: 10.1111/dom.137542018
Journal article
Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overloadmodel by modifying Smad2/3 transactivation
DOI: 10.1093/cvr/cvy1312018
Journal article
Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children
DOI: 10.1016/j.cjca.2018.02.0222018
Journal article
Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
DOI: 10.1161/CIRCULATIONAHA.117.030924